Clinical Trials Logo

Acinetobacter Bacteraemia clinical trials

View clinical trials related to Acinetobacter Bacteraemia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT01374256 Not yet recruiting - Clinical trials for Acinetobacter Bacteraemia

Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia

Start date: July 2011
Phase: N/A
Study type: Observational

Infections caused by imipenem-resistant Acinetobacter baumannii are associated with high mortality and morbidity. The treatment choices for this resistant pathogen are limited. The objective of the present proposal is to evaluate the effectiveness of combination therapy of imipenem and sulbactam in patients contracted with A. baumannii, and to correlate the clinical effect with the in vitro synergistic results.